Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease
Authors not listed
Weill Medical College of Cornell University · 2021
Abstract
The purpose of this study is to test the safety and efficacy of Selinexor and Dexamethasone and see what effects it has on AL amyloidosis.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Anonymous. (2021). Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease. <em>Weill Medical College of Cornell University</em>. https://clinicaltrials.gov/study/NCT04984330
Vancouver
Anonymous. Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease. Weill Medical College of Cornell University. 2021.
BibTeX
@misc{anon2021Seline,
title = {Selinexor for Treatment of Light Chain Amyloidosis With Relapsed/Refractory Disease},
author = {Anonymous},
journal = {Weill Medical College of Cornell University},
year = {2021},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Medy-Tox 2009
Open access · US-GOV
Double-blind, Randomized, Active Drug Comparative, Parallel Designed, Multi-center,Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of "Meditoxin® Versus Botox® in the Treatment of Glabellar Lines
Eli Lilly and Company 2016
Open access · US-GOV
A 24-Month, Phase 3, Multicenter, Placebo-Controlled Study of Efficacy and Safety of Solanezumab Versus Placebo in Prodromal Alzheimer's Disease
Journal of Neurology 2021
Citation only
The role of frailty in Parkinson’s disease: a cross-sectional study
Genentech, Inc. 2004
Open access · US-GOV
A Phase IIIb, Multicenter, Randomized, Double Masked, Sham Injection-Controlled Study of the Efficacy and Safety of Ranibizumab in Subjects With Subfoveal Choroidal Neovascularization (CNV) With or Without Classic CNV Secondary to Age Related Macular Degeneration
Montefiore Medical Center 2017
Open access · US-GOV
Study of Changes in Muscle and Fat Gene Transcription With Acarbose Treatment: a Crossover Study
Neurobiology of Disease 2007
Open access · OA